There is a lab at the University of Rochester and "[its] purpose is to study how we can use [the] SV40 promoter to make sure that DNA plasmids enter into the nucleus of the cell, even outside of the process of cell division." (Tweet 1/2)
— Sense Receptor (@SenseReceptor) November 18, 2023
Retired pharma R&D executive Sasha… pic.twitter.com/xU4vXc2Guo
There is a lab at the University of Rochester and "[its] purpose is to study how we can use [the] SV40 promoter to make sure that DNA plasmids enter into the nucleus of the cell, even outside of the process of cell division." (Tweet 1/2) Retired pharma R&D executive Sasha Latypova (@sasha_latypova) describes for Dr. Jane Ruby (@RealDrJaneRuby) how the Dean Lab at the University of Rochester in New York is focused on investigating how the SV40 promoter (1) can be used to get DNA plasmids into the nucleus of the cell.
Latypova notes the Dean Lab aims to figure out "how [they] can transfect cells with whatever [they] want to transfect cells with." She adds, "that's how he [the lab's director, David Dean] will defend himself and he'll say it's for medicinal purposes, but that's [only] a cover for biodefense." Latypova notes, "That's all they dream about: how [they] can transfect... cells." She adds, "What these [C19] vaccines are doing are transfecting your cells with foreign material and making sure it gets into the nucleus of your cell, which won't make you a transhuman, it will just make you a very, very sick human prone to cancer." 1. SV40 is an abbreviation for simian vacuolating virus 40 or simian virus 40, a polyomavirus that is found in both monkeys and humans. SV40 has been linked to cancer in humans, including mesotheliomas, lymphomas and cancers of the brain and bone. In 2002, the Lancet published evidence linking polio vaccines contaminated with SV40 to Non-Hodgkin’s lymphoma. Source: childrenshealthdefense.org/defender/sv40-
No comments:
Post a Comment